| |
| |
|
| Insider
Information: |
Baker Mark Robert |
| Relationship: |
CEO, Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
161,141 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$660,678 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
161,141 |
|
|
| Total
Value |
$660,678 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
CEO, Director |
2013-03-27 |
161,141 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2013-02-27 |
4 |
AB |
$2.71 |
$3,434 |
D/D |
1,262 |
160,491 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2013-03-27 |
4 |
AB |
$5.31 |
$3,458 |
D/D |
650 |
161,141 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2010-03-18 |
4 |
AS |
$5.33 |
$11,539 |
D/D |
(2,165) |
28,423 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-11-15 |
4 |
B |
$1.69 |
$82,332 |
D/D |
48,833 |
93,672 |
2.81 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-11-16 |
4 |
B |
$1.82 |
$90,723 |
D/D |
49,793 |
143,465 |
2.81 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
CEO |
• • – |
2012-11-19 |
4 |
B |
$1.96 |
$23,104 |
D/D |
11,800 |
155,265 |
2.81 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
officerTitle |
• – – |
2006-01-03 |
4 |
D |
$25.84 |
$12,326 |
D/D |
(477) |
2,316 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2006-04-03 |
4 |
D |
$25.61 |
$11,627 |
D/D |
(454) |
2,402 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2006-07-03 |
4 |
D |
$24.26 |
$67,152 |
D/D |
(2,768) |
2,738 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2006-10-02 |
4 |
D |
$23.03 |
$13,150 |
D/D |
(571) |
10,841 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2007-01-03 |
4 |
D |
$26.66 |
$13,597 |
D/D |
(510) |
10,953 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2007-04-02 |
4 |
D |
$24.10 |
$13,496 |
D/D |
(560) |
11,065 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2007-07-02 |
4 |
D |
$22.01 |
$69,111 |
D/D |
(3,140) |
24,760 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2007-10-01 |
4 |
D |
$22.39 |
$15,248 |
D/D |
(681) |
24,877 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2008-01-02 |
4 |
D |
$18.03 |
$15,037 |
D/D |
(834) |
25,020 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2008-04-01 |
4 |
D |
$7.67 |
$17,679 |
D/D |
(2,305) |
25,417 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2008-07-01 |
4 |
D |
$16.05 |
$71,053 |
D/D |
(4,427) |
25,925 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2008-10-01 |
4 |
D |
$13.93 |
$22,720 |
D/D |
(1,631) |
27,196 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2009-01-02 |
4 |
D |
$10.74 |
$19,858 |
D/D |
(1,849) |
27,487 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2009-04-01 |
4 |
D |
$6.65 |
$19,238 |
D/D |
(2,893) |
24,762 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2009-10-01 |
4 |
D |
$5.01 |
$18,231 |
D/D |
(3,639) |
29,915 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
General Counsel |
• – – |
2010-01-04 |
4 |
D |
$4.45 |
$19,113 |
D/D |
(4,295) |
30,588 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2010-07-01 |
4 |
D |
$5.35 |
$21,978 |
D/D |
(4,108) |
27,395 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2010-10-01 |
4 |
D |
$5.08 |
$81,138 |
D/D |
(15,972) |
29,186 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
President |
• • – |
2011-01-03 |
4 |
D |
$5.68 |
$22,800 |
D/D |
(4,014) |
29,751 |
0 |
- |
|
76 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
